{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:50:07Z","timestamp":1771048207964,"version":"3.50.1"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Purpose<\/jats:title>\n<jats:p>To evaluate the safety and efficacy of combined phacoemulsification and single iStent (G1) (iStent, Glaukos Corp. San Clemente, USA), implantation in moderately advanced primary open angle glaucoma (POAG) with 5-years follow-up.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Retrospective, interventional case series. All subjects had POAG and underwent single iStent implantation+ phaco+IOL by a single surgeon, with 5 years follow-up. Primary outcome measures: reduction in intraocular pressure (IOP) and proportion of eyes achieving at least 20% reduction of IOP at 5 years. Secondary outcome measures: number of glaucoma drops at 1 through to 5 years; change in visual field mean deviation (MD) at year 5 compared to baseline.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>35 eyes of 26 patients were included. Mean (sd) medicated pre-op IOP was 18.5 (3.2) mm Hg on mean (sd) 2.3 (1.0) medications. Mean IOP was reduced to 15.9 (4.5) mm Hg on 2.2 (0.9) drops, 15.0mm (4.5) mm Hg on 2.3 (0.9) drops, 15.6 (3.6) mm Hg on 2.5 (1.0) drops, 15.7 (4.43) mmHg on 2.6 (1.0) drops and 14.7 (3.02) mmHg (P&lt;0.001) on 2.7 (1.14) drops (P = 0.06) from 1 through to 5 years. At year 5, 62% of eyes had achieved at least 20% reduction in IOP. MD reduced from -8 (8.1) dB to -10.7 (13.4) dB over 5 years (p = 0.8) at 0.54dB\/ annum. One eye required filtering surgery. There were no sight-threatening complications.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This study showed sustained IOP reduction and excellent safety profile for single iStent implantation. Uniquely it provides data for a more severe stage of glaucoma, and also visual field data, which indicated no significant change through 5 years.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0257015","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T17:30:40Z","timestamp":1631813440000},"page":"e0257015","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["5-year outcomes of single iStent (G1) trabecular microbypass implantation with phacoemulsification in moderately advanced primary open angle glaucoma"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6610-0125","authenticated-orcid":true,"given":"Ejaz","family":"Ansari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"key":"pone.0257015.ref001","article-title":"Global Causes of Blindness and Distance Vision Impairment 1990\u20132020: A Systematic Review and Meta-Analysis","author":"SR Flaxman","year":"2017","journal-title":"The Lancet Global health"},{"issue":"10","key":"pone.0257015.ref002","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial","volume":"120","author":"A Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"pone.0257015.ref003","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-158-4-201302190-00008","article-title":"Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. preventive services task force","volume":"158","author":"MV Boland","year":"2013","journal-title":"Ann Intern Med"},{"issue":"11 Suppl","key":"pone.0257015.ref004","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.ophtha.2009.06.024","article-title":"A comprehensive perspective on patient adherence to topical glaucoma therapy","volume":"116","author":"JC Tsai","year":"2009","journal-title":"Ophthalmology"},{"issue":"1","key":"pone.0257015.ref005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ajo.2005.02.013","article-title":"Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS)","volume":"140","author":"HD Jampel","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"pone.0257015.ref006","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/ICU.0000000000000549","article-title":"New developments in tube shunt surgery","volume":"30","author":"J Chen","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"issue":"12","key":"pone.0257015.ref007","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jamaophthalmol.2013.5059","article-title":"Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis","volume":"131","author":"E Rulli","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"pone.0257015.ref008","doi-asserted-by":"crossref","first-page":"e0183142","DOI":"10.1371\/journal.pone.0183142","article-title":"Minimallyinvasive glaucoma surgeries (MIGS) for open angle glaucoma: a systematic review and meta-analysis","volume":"12","author":"C Lavia","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"pone.0257015.ref009","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40662-019-0154-1","article-title":"Micro-invasive glaucoma surgery\u2013an interventional glaucoma revolution","volume":"6","author":"M Shah","year":"2019","journal-title":"Eye Vis Lond Engl"},{"issue":"2","key":"pone.0257015.ref010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/ICU.0b013e32834ff1e7","article-title":"Micro-invasive glaucoma surgery: current perspectives and future directions","volume":"23","author":"H Saheb","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"pone.0257015.ref011","first-page":"189","article-title":"Minimally invasive glaucoma surgery: current status and future prospects","volume":"10","author":"M Grace","year":"2016","journal-title":"Clin Ophthalmol Auckl NZ"},{"issue":"8","key":"pone.0257015.ref012","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jcrs.2012.03.025","article-title":"Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up","volume":"38","author":"ER Craven","year":"2012","journal-title":"J Cataract Refract Surg"},{"key":"pone.0257015.ref013","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2147\/OPTH.S114306","article-title":"Clinical evaluation of a trabecular microbypass stent with phacoemulsification in patients with open-angle glaucoma and cataract","volume":"10","author":"TJ Ferguson","year":"2016","journal-title":"Clin Ophthalmol Auckl NZ"},{"issue":"2","key":"pone.0257015.ref014","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40123-016-0065-3","article-title":"Newly diagnosed primary open-angle glaucoma randomized to 2 trabecular bypass stents or prostaglandin: outcomes through 36 months","volume":"5","author":"SD Vold","year":"2016","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"pone.0257015.ref015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ophtha.2010.07.007","article-title":"Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract","volume":"118","author":"TW Samuelson","year":"2011","journal-title":"Ophthalmology"},{"issue":"3","key":"pone.0257015.ref016","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jcrs.2018.10.029","article-title":"Long term effectiveness and safety of trabecular microbypass stent implantation with cataract surgery in patients with glaucoma or ocular hypertension: five-year outcomes","volume":"45","author":"TH Neuhann","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"pone.0257015.ref017","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2147\/OPTH.S247910","article-title":"iStent Trabecular Microbypass Stent Implantation with Phacoemulsification in Patients with Open-Angle Glaucoma: 6-Year Outcomes","volume":"14","author":"TJ Ferguson","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"10","key":"pone.0257015.ref018","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.ophtha.2004.04.030","article-title":"Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma","volume":"111","author":"MS Juzych","year":"2004","journal-title":"Ophthalmology"},{"issue":"1","key":"pone.0257015.ref019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/IJG.0000000000000825","article-title":"Evaluation of a trabecular microbypass stent with cataract extraction in severe primary open-angle glaucoma","volume":"27","author":"T Ferguson","year":"2018","journal-title":"J Glaucoma"},{"issue":"1","key":"pone.0257015.ref020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ogla.2018.05.005","article-title":"Distribution and Rates of Visual Field Loss across Different Disease Stages in Primary Open-Angle Glaucoma","volume":"1","author":"S Yousefi","year":"2018","journal-title":"Ophthalmol Glaucoma"},{"issue":"5","key":"pone.0257015.ref021","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jcrs.2007.12.045","article-title":"Long-term effects of phacoemulsification with intraocular lens implantation in normotensive and ocular hypertensive eyes","volume":"34","author":"BJ Poley","year":"2008","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"pone.0257015.ref022","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/IJG.0000000000000643","article-title":"The Effects of Phacoemulsification on Intraocular Pressure and Topical Medication Use in Patients With Glaucoma: A Systematic Review and Meta-analysis of 3-Year Data","volume":"26","author":"JJ Armstrong","year":"2017","journal-title":"J Glaucoma"},{"key":"pone.0257015.ref023","first-page":"2057","article-title":"A prospective 3-year follow-up trial of implantation of two trabecular microbypass stents in open-angle glaucoma","volume":"9","author":"ED Donnenfeld","year":"2015","journal-title":"Clin Ophthalmol Auckl NZ"},{"issue":"4","key":"pone.0257015.ref024","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jcrs.2018.11.005","article-title":"Trabecular microbypass stent implantation in pseudophakic eyes with open-angle glaucoma: long-term results","volume":"45","author":"TJ Ferguson","year":"2019","journal-title":"J Cataract Refract Surg"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0257015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T17:30:56Z","timestamp":1631813456000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0257015"}},"subtitle":[],"editor":[{"given":"Ahmed","family":"Awadein","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0257015","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]}}}